trial

Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients

NCTId NCT01448499
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by Geha Mental Health Center
Primary completion 2013-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2011-10
Primary completion
2013-10
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
ClozapineAmisulpride

Sponsors

Geha Mental Health CenterLead Sponsor

Sites

1 total
Petah Tikva, Israel

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2013-10
Status
WITHDRAWN
relationships
The graph out of here
drug
Clozapine
drug
Amisulpride
drug
lead_sponsor
Geha Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
Treatment Resistant Disorders
indication